Skip to content
Disclosery

Blackcrane Capital, LLC

Follow

13F filer, CIK 1720745, BELLEVUE, WA

Blackcrane Capital, LLC reported $63,451,000 across 13 holdings for the quarter ended 2021-03-31, in a 13F-HR filed 2021-05-13. Its ten largest share positions make up 94.26% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001720745-21-000003

Period
2021-03-31
Reported value
$63.5M
Holdings
13
Top 10 weight
94.26%
New
4
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AUPHnew+503,248$6.54M
BABAnew+10,041$2.28M
RCELadded+109,690$2.17M
PROFadded+103,758$2.09M
HDBnew+20,978$1.63M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AXONICS INCreduced-57,740-$3.46M
TAKreduced-20,665-$2.44M
BIOHAVEN PHARMACEUTICAL HOLDexited-25,641-$2.2M
NBIXexited-11,499-$1.1M
OTEXreduced-8,400-$401K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2021

Share positions as resolved from 13F-HR 0001720745-21-000003, largest first. % of portfolio is the value over $63,451,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WIXWIX COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 62,379 shares; 2020Q3: 41,610 shares; 2020Q4: 42,363 shares; 2021Q1: 43,963 shares 43,963$12.3M19.35%+1,600Timeline
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 175,301 shares; 2020Q3: 196,924 shares; 2020Q4: 341,767 shares; 2021Q1: 445,525 shares 445,525$8.96M14.12%+103,758Timeline
RCELAVITA MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 921,663 shares; 2020Q3: 474,982 shares; 2020Q4: 308,504 shares; 2021Q1: 418,194 shares 418,194$8.29M13.06%+109,690Timeline
OTEXOPEN TEXT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: 151,800 shares; 2021Q1: 143,400 shares 143,400$6.84M10.78%-8,400Timeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 503,248 shares 503,248$6.54M10.3%newTimeline
NICENICE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 43,657 shares; 2020Q3: 25,952 shares; 2020Q4: 26,721 shares; 2021Q1: 27,418 shares 27,418$5.98M9.42%+697Timeline
AXONICS INCAXONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 428,359 shares; 2020Q3: 124,787 shares; 2020Q4: 124,736 shares; 2021Q1: 66,996 shares 66,996$4.01M6.32%-57,740
MYOVANT SCIENCES LTDMYOVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: 69,695 shares; 2021Q1: 142,065 shares 142,065$2.92M4.61%+72,370
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 10,041 shares 10,041$2.28M3.59%newTimeline
TAKTAKEDA PHARMACEUTICAL CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 25,723 shares; 2020Q3: 25,723 shares; 2020Q4: 35,236 shares; 2021Q1: 14,571 shares 14,571$1.72M2.72%-20,665Timeline
HDBHDFC BANK LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 20,978 shares 20,978$1.63M2.57%newTimeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: 14,039 shares; 2020Q3: 5,904 shares; 2020Q4: 4,555 shares; 2021Q1: 4,826 shares 4,826$1.14M1.79%+271Timeline
CLPTCLEARPOINT NEURO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 41,266 shares 41,266$872K1.37%newTimeline

Sold out in Q1 2021

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BIOHAVEN PHARMACEUTICAL HOLDBIOHAVEN PHARMACEUTICAL HOLD25,641$2.2Mshares
NBIXNEUROCRINE BIOSCIENCES INC11,499$1.1Mshares

How Q1 2021 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001720745-21-000003 base2021-05-13acceptance time not in the bulk data set